Improving health for patients with rheumatic diseases through advanced research and technology.
Official title: Washington University Rheumatic Diseases Research Resource-based Center
Funded at Washington University · NIH-10925271 · Data updated 2026-11-12
This study at Washington University is looking for ways to improve the health of people with rheumatic diseases by understanding how inflammation and autoimmunity work, so they can create personalized treatments that really fit each person's needs.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 1, 2018 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $777,498 |
| NIH project number | 5P30AR073752-07 |
| Project ID | NIH-10925271 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with various rheumatic diseases, such as rheumatoid arthritis or lupus.
✕Less likely to help
Patients with non-rheumatic conditions or those not diagnosed with any autoimmune diseases may not benefit from this research.
What this research studies
This research initiative at Washington University focuses on enhancing the health of patients suffering from rheumatic diseases by exploring the underlying mechanisms of inflammation and autoimmunity. It aims to accelerate clinical and translational research to support precision medicine, which tailors treatments to individual patient needs. The program also emphasizes advancements in genome engineering and regenerative medicine to develop innovative treatment strategies. By fostering collaboration among experts and utilizing cutting-edge technologies, the initiative seeks to improve research efficiency and address urgent health challenges, including those posed by the COVID-19 pandemic.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for patients with rheumatic diseases.
How similar studies have gone: Previous research in rheumatic diseases has shown promise in utilizing similar collaborative and innovative approaches, indicating potential for success.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Pham, Christine T. — Washington University
- Study coordinator: Pham, Christine T.
Related research
Other NIH-funded projects on the same topics.
-
Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups with Rheumatic Diseases
A patient-facing program tests a multi-modal approach using storytelling videos and trained patient navigators to help Black and Latinx adults with autoimmune rheumatic diseases get recommended COVID-19 vaccines and boosters.
-
How health policies affect people with systemic autoimmune and rheumatic conditions
This project looks at how health policies and medical care affect health and pregnancy outcomes for reproductive-age women with systemic autoimmune and rheumatic diseases.
-
Long-term immune and health effects of COVID-19 in people with autoimmune rheumatic diseases
This project looks at how COVID-19 changes immune responses and causes lingering symptoms in people with autoimmune rheumatic diseases like rheumatoid arthritis and lupus.
-
How health policies impact women with autoimmune diseases during pregnancy
This study is looking at how health policies affect women with autoimmune and rheumatic diseases during pregnancy, aiming to understand their experiences and access to care, so we can better support their health and treatment options.
-
Training new scientists in rheumatic diseases
This program is training new scientists to explore the causes and treatments of rheumatic diseases, like arthritis, by working together at the University of Pennsylvania and the Children’s Hospital of Philadelphia, so they can help improve care for patients of all ages.
-
Helping Black and Latinx patients with rheumatic diseases get recommended COVID-19 vaccines
This project helps Black and Latinx adults living with autoimmune rheumatic diseases get their recommended COVID-19 vaccines.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.